Kuros Biosciences - Funding ^Investors

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy : SIX Swiss ExchangeFiscal Year: January-DecemberReporting Currency: CHFTicker Symbol: KURNKuros Biosciences AG Company Description - Stock /?